Tag: ulcerative colitis treatment
Asia-Pacific’s IBD Crisis: Why Early Action Could Change Everything
Asia-Pacific countries are developing new strategies to tackle rising IBD rates through early intervention and comprehensive care. This shift could transform outcomes for millions living with Crohn’s disease and ulcerative colitis in the region.
New Hope: STELARA Seeks FDA Approval for Kids with UC
Johnson & Johnson has submitted an FDA request for STELARA approval in pediatric ulcerative colitis patients. This could become the first biologic targeting dual inflammation pathways specifically for children with UC, offering new hope for families with limited treatment options.
After Surgery, IBD Can Still Surprise Us: A Facial Wound’s Message
A woman who thought her ulcerative colitis was cured by surgery developed a rare facial skin condition years later, revealing that IBD can continue affecting the body in unexpected ways. This case highlights why ongoing vigilance and comprehensive care remain important even after major IBD surgery.
New Once-Monthly UC Treatment Approved: What Patients Need to Know
The FDA has approved Omvoh, the first once-monthly injection for ulcerative colitis maintenance therapy. This breakthrough could significantly reduce treatment burden for people with moderate to severe UC.
AI Revolution: New Hope for Better IBD Management and Care
Artificial intelligence is revolutionizing IBD care with the potential to predict flares, personalize treatments from the start, and give patients more control over their condition. While still developing, these AI advances represent genuine hope for better management of Crohn’s disease and ulcerative colitis.
AI Breakthrough Reveals How Two Proteins Could Protect Against Crohn’s
Cambridge researchers used AI to discover two proteins that work together to protect against Crohn’s disease, opening doors to personalized prevention and treatment approaches. This breakthrough could transform how we understand and manage IBD.
New Clinical Leader Brings Hope to GI Treatment Development
Palisade Bio has appointed Dr. Sharon Skare as VP of Clinical Operations to advance PALI-2108, a promising new GI therapy. Her 30+ years of experience could accelerate development of treatments for conditions with limited options.
Better IBD Treatments on the Horizon: What Growth Means for Patients
Market analysis shows unprecedented growth in IBD research and treatment development, with new biologics, personalized medicine, and digital health platforms on the horizon. Here’s what this expansion means for patients and families managing Crohn’s disease and ulcerative colitis.
New UC Research Tackles Bowel Urgency – The Symptom That Controls Your Life
New clinical trial data shows promising improvements in bowel urgency for ulcerative colitis patients, addressing the symptom that often controls daily life more than any other UC symptom.
New UC Treatment Shows Promise in Just 3 Days
New clinical trial data shows OMVOH, an FDA-approved UC treatment, can start improving symptoms in just three days while maintaining benefits for a full year. This rapid-acting approach could change how we experience UC treatment, offering hope for faster relief and long-term stability.
